Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725725 | SCV000338875 | uncertain significance | not provided | 2017-09-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001081894 | SCV000559436 | likely benign | Walker-Warburg congenital muscular dystrophy | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725725 | SCV000722780 | likely benign | not provided | 2021-04-08 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000725725 | SCV001475117 | likely benign | not provided | 2020-08-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348001 | SCV002646800 | likely benign | Cardiovascular phenotype | 2019-09-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000725725 | SCV003832615 | likely benign | not provided | 2023-08-25 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330623 | SCV004038560 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001828220 | SCV002088957 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2019-11-11 | no assertion criteria provided | clinical testing |